Specgx Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SPECGX LLC, and what generic alternatives to SPECGX LLC drugs are available?
SPECGX LLC has sixty approved drugs.
There is one US patent protecting SPECGX LLC drugs.
There are ten patent family members on SPECGX LLC drugs in nine countries and thirty supplementary protection certificates in ten countries.
Summary for Specgx Llc
| International Patents: | 10 |
| US Patents: | 1 |
| Tradenames: | 47 |
| Ingredients: | 31 |
| NDAs: | 60 |
| Drug Master File Entries: | 73 |
Drugs and US Patents for Specgx Llc
Expired US Patents for Specgx Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Specgx Llc | PAMELOR | nortriptyline hydrochloride | SOLUTION;ORAL | 018012-001 | Approved Prior to Jan 1, 1982 | 3,922,305 | ⤷ Subscribe |
| Specgx Llc | EXALGO | hydromorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021217-004 | Aug 24, 2012 | 5,702,725 | ⤷ Subscribe |
| Specgx Llc | EXALGO | hydromorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021217-002 | Mar 1, 2010 | 5,914,131 | ⤷ Subscribe |
| Specgx Llc | RESTORIL | temazepam | CAPSULE;ORAL | 018163-003 | Oct 25, 1991 | 5,030,632 | ⤷ Subscribe |
| Specgx Llc | METHYLIN | methylphenidate hydrochloride | SOLUTION;ORAL | 021419-002 | Dec 19, 2002 | 7,691,880 | ⤷ Subscribe |
| Specgx Llc | PAMELOR | nortriptyline hydrochloride | CAPSULE;ORAL | 018013-001 | Approved Prior to Jan 1, 1982 | 3,922,305 | ⤷ Subscribe |
| Specgx Llc | EXALGO | hydromorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021217-004 | Aug 24, 2012 | 5,914,131 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SPECGX LLC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Oral Solution | 5 mg/5 mL and 10 mg/5 mL | ➤ Subscribe | 2010-04-13 |
International Patents for Specgx Llc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2005035000 | ⤷ Subscribe |
| Canada | 2540052 | ⤷ Subscribe |
| Mexico | PA06003725 | ⤷ Subscribe |
| Austria | 526988 | ⤷ Subscribe |
| Japan | 4959335 | ⤷ Subscribe |
| China | 1867359 | ⤷ Subscribe |
| Japan | 2007508313 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Specgx Llc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0566709 | C300152 | Netherlands | ⤷ Subscribe | PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405 |
| 0566709 | SPC/GB04/012 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| 0901368 | C300523 | Netherlands | ⤷ Subscribe | PRODUCT NAME: FENTANYL; REGISTRATION NO/DATE: EU/2/11/127/001 20111006 |
| 2316456 | LUC00054 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: NALTREXONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR NALTREXONE HYDROCHLORIDE, AND BUPROPION OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BUPROPION HYDROCHLORIDE; AUTHORISATION NUMBER AND DATE: EU/1/14/988 20150330 |
| 0836511 | 122006000022 | Germany | ⤷ Subscribe | PRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126 |
| 1644019 | 301019 | Netherlands | ⤷ Subscribe | PRODUCT NAME: LISDEXAMFETAMINE, DESGEWENST IN DE VORM VAN EEN MESYLAAT- OF HYDROCHLORIDEZOUT DAARVAN; NATIONAL REGISTRATION NO/DATE: RVG 124498 20190528; FIRST REGISTRATION: GB PL 08081/0050-52 20130201 |
| 1644019 | 2013/038 | Ireland | ⤷ Subscribe | PRODUCT NAME: LISDEXAMFETAMINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY A MESYLATE SALT; NAT REGISTRATION NO/DATE: PA0689/006/001 PA0689/006/002 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
